Patient assessment is one of the most heavily weighted areas on the current VA-BC examination blueprint. According to the current Vascular Access Certification Corporation content outline, Patient Assessment represents 18% of the scored examination, or approximately 23 of the 125 scored questions. CURRENT VA-BC BLUEPRINT ARTICLE
This domain goes far beyond simply looking for a vein. A vascular access clinician must integrate the patient's medical history, vascular pathology, comorbidities, laboratory findings, prescribed therapy, anticipated duration, vessel-preservation needs, psychosocial considerations, ability to maintain a device, and available imaging before recommending an access plan. The current VA-BC exam also includes questions written at application and analysis levels, meaning candidates may need to determine the best course of action when several answers initially appear reasonable. Vascular Access Certification
The following 10 questions are designed to test that type of clinical reasoning.
These are independently developed practice questions and are not actual VA-BC examination questions.
Question 1: CKD and Vessel Preservation
A 64 year old patient with diabetes, hypertension, and stage 4 chronic kidney disease is admitted with osteomyelitis. The patient's eGFR is 22, and the treatment plan includes four weeks of intravenous antimicrobial therapy. The patient's right basilic vein is large and compressible, and the provider requests a right arm PICC. The patient has never received dialysis and has no previous vascular access device history.
What is the BEST action by the vascular access clinician?
A. Insert a single-lumen PICC into the right basilic vein to minimize catheter diameter.
B. Insert a midline in the left basilic vein to preserve the patient's dominant right arm.
C. Pause upper-arm device placement and coordinate a vein-preservation plan with the appropriate care team.
D. Place the requested PICC because future dialysis access is not relevant until dialysis begins.
Correct Answer: C
Rationale
The critical clue is not simply that the patient needs four weeks of IV therapy. The more important patient-assessment finding is advanced CKD with the possibility of future hemodialysis access.
A strong test-taking approach is to identify which piece of the history could have long-term consequences that are not immediately obvious. In this case, placing a PICC through a potentially valuable upper arm vein may cause thrombosis, stenosis, or vessel injury that could compromise future dialysis-access options. KDOQI specifically emphasizes vessel preservation for patients with CKD in whom future dialysis access may be needed. National Kidney Foundation
Why C is correct: Before cannulating an upper-arm vein, the vascular access clinician should recognize the CKD history, stop the automatic progression from "needs long term IV therapy" to "needs PICC," and coordinate an individualized vein preservation strategy. The final access plan depends on the patient's renal prognosis, therapy requirements, available vessels, and multidisciplinary recommendations.
Why A is misleading: Choosing a smaller catheter is generally beneficial, but a smaller PICC does not eliminate the underlying vessel-preservation concern.
Why B is misleading: A midline avoids central tip placement but still occupies an upper arm vein that may have future value. Simply switching arms does not solve the broader preservation problem.
Why D is incorrect: Vessel preservation begins before dialysis becomes necessary. Waiting until the patient requires dialysis may mean important vascular options have already been lost.
Test-Taking Pearl
When a question includes advanced CKD, do not focus only on the immediate infusion. Think several years ahead: Could what I do today affect this patient's future dialysis access?
Question 2: Therapy Duration Versus Device Selection
A 52-year-old patient requires 12 additional days of IV cefazolin for a complicated infection. The medication is peripherally compatible. Several short peripheral IVs have infiltrated or become nonfunctional within 24 to 48 hours despite ultrasound guided placement. Ultrasound assessment shows an adequate upper arm vein with no evidence of thrombosis. The patient has normal renal function and no history requiring vessel preservation.
Which access strategy is MOST appropriate based on the assessment?
A. Consider a midline catheter based on therapy characteristics, duration, and repeated PIV failure.
B. Insert a PICC because any IV therapy extending beyond seven days requires central access.
C. Continue replacing ultrasound guided PIVs because the infusate remains peripherally compatible.
D. Request an implanted port because repeated peripheral-device failure predicts long term access difficulty.
Correct Answer: A
Rationale
This question is designed to make several answers sound defensible. The key is to integrate three variables simultaneously:
What is being infused? How long is it needed? How have previous devices performed?
The therapy is peripherally compatible, the expected duration is intermediate rather than months, and multiple short PIVs have already failed. MAGIC guidance has historically favored midlines or ultrasound guided peripheral access over PICCs for many peripherally compatible therapies in the 6-to-14-day range. PubMed
Why A is correct: A midline addresses both the anticipated duration and the demonstrated inability of short PIVs to provide reliable therapy without automatically escalating to central venous access.
Why B is incorrect: There is no universal rule that IV therapy beyond seven days automatically requires a PICC. Duration is only one component of device selection.
Why C is misleading: A short PIV could theoretically deliver cefazolin, but the patient's device performance history matters. Repeated failures are evidence that continuing the same strategy may not be appropriate.
Why D is incorrect: An implanted port would generally be excessive for a defined 12-day course without an ongoing long-term indication.
Test-Taking Pearl
Do not choose devices from duration alone. VA-BC-style reasoning usually requires you to combine infusate + duration + patient factors + previous device performance.
Question 3: Catheter to Vein Ratio
A patient requires a double-lumen PICC. The smallest catheter capable of supporting the prescribed therapy has an external diameter of 1.67 mm. Your facility requires a catheter-to-vein diameter ratio of 45% or less.
Ultrasound assessment identifies the following vessels. Which is the BEST candidate based solely on catheter to vein ratio?
A. A cephalic vein measuring 3.1 mm at the proposed insertion location.
B. A brachial vein measuring 3.4 mm at the proposed insertion location.
C. A basilic vein measuring 3.6 mm at the proposed insertion location.
D. A basilic vein measuring 4.0 mm at the proposed insertion location.
Correct Answer: D
Rationale
The formula is:
Catheter diameter ÷ vessel diameter × 100
For the 4.0-mm vessel:
1.67 ÷ 4.0 × 100 = approximately 41.8%
That satisfies the facility's stated maximum.
The other choices do not:
A 3.1-mm vessel produces a ratio of approximately 54%.
A 3.4-mm vessel produces approximately 49%.
A 3.6-mm vessel produces approximately 46%.
Why D is correct: It is the only listed vessel that meets the threshold provided in the question.
But there is another important point: the question says "based solely on catheter to vein ratio." That language matters. In actual practice, vein diameter alone would not determine the final site. Depth, course, compressibility, nearby arteries and nerves, history of thrombosis, limb restrictions, and the patient's overall vascular plan still require assessment.
Why A can tempt you: Cephalic veins are sometimes appealing because of their superficial location, but anatomy cannot override an unacceptable ratio.
Why B can tempt you: The brachial vein may appear technically accessible, but the calculated ratio still exceeds the limit provided.
Why C is especially misleading: At 3.6 mm, the vessel is very close to the threshold. On an exam, however, "almost within the standard" is still outside the parameter supplied in the question.
Test-Taking Pearl
When the stem provides an objective threshold, calculate before applying preference. Don't let "basilic versus brachial versus cephalic" distract you from the actual variable being tested.
Question 4: Home Therapy and the Ability to Maintain the Device
A 78-year-old patient will require six weeks of home parenteral nutrition. The patient lives alone and has mild cognitive impairment. During teaching, the patient repeatedly contaminates the demonstration supplies and cannot correctly repeat the steps for accessing or protecting the catheter. A nearby daughter visits approximately once every two weeks. The patient's vascular anatomy is suitable for several central access options.
What should MOST influence the next step in the vascular access plan?
A. Select the easiest central device to insert because all central devices require comparable home care.
B. Assess and arrange reliable caregiver, home-infusion, and community support before finalizing the plan.
C. Change to peripheral access because inability to perform central line care contraindicates central therapy.
D. Proceed with the preferred central device and repeat education immediately before hospital discharge.
Correct Answer: B
Rationale
This question tests a part of patient assessment that clinicians sometimes overlook: a device does not exist independently of the environment in which it must be maintained.
The current VA-BC Patient Assessment outline specifically includes available resources for maintaining devices, including family and community support. Vascular Access Certification
The patient needs a therapy that generally requires appropriate central access, but assessment has uncovered a significant safety problem: the patient cannot currently perform necessary device-care behaviors independently.
Why B is correct: The next step is not automatically to abandon central therapy or simply proceed with insertion. The clinician should determine whether safe support can be established through family, home health, home infusion services, case management, or another appropriate resource.
Why A is incorrect: Different devices have different maintenance requirements, but choosing whichever device is easiest to insert ignores the patient's ability to safely maintain it after discharge.
Why C is misleading: The patient's difficulty with catheter care does not make a peripherally inappropriate therapy suddenly appropriate for peripheral administration.
Why D is inadequate: More education may help, but the scenario already demonstrates persistent difficulty. Repeating the same intervention without addressing the underlying cognitive and social limitations is not an adequate assessment-based plan.
Test-Taking Pearl
When a question mentions home therapy, cognition, caregiver availability, transportation, supplies, or living situation, those facts are probably not filler. Ask: Can this device be safely maintained outside the hospital?
Question 5: When a Negative Duplex Is Not Enough
A patient with multiple previous central venous catheters presents for long-term vascular access. Assessment reveals mild right arm edema and prominent superficial veins across the upper chest. Peripheral ultrasound shows compressible upper arm veins without evidence of acute upper-extremity DVT. The clinician is considering a right-sided central access device.
What is the MOST appropriate interpretation of these findings?
A. A negative upper arm duplex excludes clinically significant obstruction affecting central device placement.
B. Compressible peripheral veins indicate the right side is preferable for central venous catheter insertion.
C. The collateral veins and edema warrant assessment for more proximal central venous obstruction.
D. The absence of peripheral thrombus indicates that catheter related venous disease is unlikely.
Correct Answer: C
Rationale
The trap is assuming that because the veins visible with routine upper-extremity ultrasound are compressible, the entire venous pathway is normal.
It isn't necessarily.
The patient's arm edema, visible chest-wall collaterals, and history of multiple central devices should raise suspicion for more proximal venous stenosis or occlusion. Depending on the clinical circumstances, further assessment may involve CT venography, MR venography, fluoroscopic venography, or other appropriate imaging. Imaging technologies, including venographic studies, are specifically included in the current Patient Assessment domain. Vascular Access Certification
Why C is correct: The clinician should integrate the physical assessment and history rather than allowing one negative test to terminate the evaluation.
Why A is incorrect: Peripheral duplex ultrasound does not necessarily visualize or exclude every central venous lesion.
Why B is misleading: A compressible basilic or brachial vein may be suitable for cannulation locally while a more proximal obstruction compromises the overall venous pathway.
Why D is incorrect: Previous central access itself is a relevant vascular-history finding. Absence of an acute peripheral DVT does not erase the possibility of chronic central stenosis or occlusion.
Test-Taking Pearl
When physical findings and one diagnostic test disagree, don't automatically trust the reassuring test. Ask whether the test actually evaluates the pathology suggested by the patient's presentation.
Question 6: Good Veins Do Not Make Every Therapy Peripheral
A patient with newly diagnosed malignancy is scheduled to receive a continuous 96-hour infusion of an antineoplastic vesicant. The patient has excellent visible and palpable peripheral veins and requests a peripheral IV because they do not want "a central line unless absolutely necessary."
Which assessment conclusion is BEST?
A. Therapy characteristics outweigh vein quality, and an appropriate central-access strategy should be discussed.
B. Excellent peripheral veins make peripheral administration reasonable if the site is checked frequently.
C. A midline provides sufficient protection because the catheter tip terminates in a larger upper-arm vein.
D. Peripheral access is preferred because limiting central-catheter exposure reduces infection and thrombosis risk.
Correct Answer: A
Rationale
The distractor in this question is the phrase "excellent peripheral veins."
Vascular access assessment is not simply an anatomical exercise. The clinician must first determine whether the prescribed therapy is appropriate for peripheral administration.
A continuous vesicant infusion creates a substantially different risk profile than a routine peripherally compatible medication. The fact that a vein is easy to cannulate does not change the consequences of extravasation.
Why A is correct: The clinician should allow therapy characteristics to guide the access requirement and then incorporate the patient's preferences into choosing among appropriate options. Contemporary device-selection guidance recognizes vesicant therapy as an important indication when evaluating central access. PubMed
Why B is misleading: Frequent assessment is important when peripheral vesicants are appropriately administered, but monitoring does not convert a high-risk prolonged infusion into an ideal peripheral therapy.
Why C is incorrect: A midline is still a peripheral device. Moving the catheter tip farther up the arm does not make it central access.
Why D is misleading: Avoiding unnecessary central access is good practice, but the safest device is not necessarily the device with the fewest theoretical complications. The device must first be appropriate for the prescribed therapy.
Test-Taking Pearl
When faced with beautiful veins versus a high risk infusate, evaluate the medication first. Anatomy tells you where you can put a catheter. Therapy tells you what kind of catheter the patient needs.
Question 7: When Both Arms Have Problems
A patient requires six weeks of intravenous therapy. The right arm has a functioning arteriovenous fistula created for hemodialysis. The left arm has a history of catheter associated axillary and subclavian DVT, and the patient continues to have intermittent left arm edema. A request is placed for a PICC.
What is the BEST vascular access response?
A. Place the PICC in the left arm because the previous thrombosis has already been treated.
B. Place the PICC in the right arm because a functioning fistula confirms adequate venous circulation.
C. Select whichever arm has the largest basilic vein on ultrasound and use the smallest catheter.
D. Avoid automatic upper-extremity placement and evaluate alternative access through multidisciplinary planning.
Correct Answer: D
Rationale
This scenario is difficult because there is no obviously "good" arm.
That is exactly the point.
The right arm contains a functioning dialysis access that should be protected. The left arm has a history suggesting significant venous pathology. Choosing between two problematic extremities based only on vein diameter ignores the patient's larger vascular-access history.
Why D is correct: The safest approach is to recognize that routine upper-extremity PICC placement may jeopardize important vascular resources or worsen existing pathology. The vascular access clinician should escalate the assessment and collaborate with nephrology, the treating team, interventional specialists, or other appropriate clinicians to determine a viable alternative.
Why A is incorrect: A previous DVT is highly relevant even after treatment. Residual obstruction, altered flow, recurrence risk, and central venous involvement may remain clinically important.
Why B is incorrect: A functioning AV fistula is something to protect, not evidence that the arm is available for unrelated vascular access.
Why C is misleading: Selecting the largest vessel and smallest catheter is generally desirable, but vessel diameter does not override major patient-specific contraindications or preservation priorities.
Test-Taking Pearl
If every obvious option has a serious downside, the correct answer may be to stop treating the problem as a routine insertion. Escalating for individualized vascular planning can be the safest clinical decision.
Question 8: Developmental and Communication Assessment
An 8-year-old child with autism spectrum disorder requires approximately seven days of peripherally compatible IV therapy. The child is minimally verbal and becomes extremely distressed when unfamiliar clinicians touch either arm. The parent reports that restraint dramatically increases the child's agitation but that the child usually cooperates when procedures are explained visually and performed with a familiar caregiver present.
What is the BEST initial vascular access approach?
A. Perform ultrasound immediately so device selection can be based on anatomy before behavioral factors interfere.
B. Incorporate caregiver input and the child's communication and sensory needs into the access plan first.
C. Request sedation because predictable distress makes awake vascular access attempts unnecessarily traumatic.
D. Select the longest-dwell peripheral device available to reduce the possibility of repeated insertion attempts.
Correct Answer: B
Rationale
This question intentionally provides several technically reasonable interventions, but it asks what should happen first.
Patient assessment includes more than physiology. The current blueprint explicitly includes growth and development, cognitive issues, psychosocial concerns, and communication needs. Vascular Access Certification
The parent has given valuable information about strategies that improve this child's ability to participate in care.
Why B is correct: Incorporating the patient's individual communication style, sensory needs, caregiver knowledge, and coping strategies should shape how the assessment and subsequent procedure are performed.
Why A is misleading: Ultrasound assessment may ultimately be appropriate, but immediately approaching a highly distressed child with equipment before establishing a workable communication plan may make the entire procedure harder.
Why C is incorrect: Sedation may occasionally be necessary, but distress alone does not mean sedation should be the automatic first solution.
Why D is misleading: Reducing repeated procedures is an excellent goal, but device dwell characteristics should be considered after the broader patient assessment establishes what therapy and approach are appropriate.
Test-Taking Pearl
Watch for the word first. When developmental, cognitive, language, or sensory needs appear in the stem, patient-centered assessment often comes before technical execution.
Question 9: Interpreting Laboratory Values in Context
A hospitalized patient requires reliable vascular access for a treatment expected to continue for several weeks. Platelet count is 48,000/µL and has been stable for two days. INR is 1.2. The patient has no active bleeding but is receiving medications that may affect bleeding risk. The provider requests PICC placement.
Which response demonstrates the BEST patient-assessment reasoning?
A. Cancel the procedure because a platelet count below 50,000/µL is an absolute contraindication to PICC placement.
B. Proceed because normal INR establishes that the patient's overall procedural bleeding risk is acceptable.
C. Assess the complete bleeding-risk picture, platelet trend, medications, procedure, and applicable institutional guidance.
D. Transfuse platelets before placement because vascular access procedures require normalization of the platelet count.
Correct Answer: C
Rationale
This is a classic example of the danger of treating a single laboratory value as the entire patient assessment.
The exam blueprint specifically includes laboratory values within medical-history assessment, but recognizing a laboratory abnormality is only the first step. The clinician must determine what that finding means in context.
Why C is correct: The platelet count matters, but so do the trend, active bleeding, medication profile, procedural technique, planned device, available evidence, and institutional or specialist guidance. The vascular access clinician should assess these variables rather than inventing a universal cutoff from one number.
Why A is misleading: Round numbers such as 50,000 are memorable and therefore attractive exam distractors. A threshold used in one procedure, facility, or clinical situation should not automatically be converted into an absolute contraindication for every vascular-access procedure.
Why B is incorrect: INR evaluates only part of the coagulation picture. A normal INR does not neutralize thrombocytopenia, medication effects, platelet dysfunction, or other bleeding risks.
Why D is incorrect: Prophylactic transfusion should not be assumed to be necessary simply because a laboratory result is abnormal. Clinical circumstances and appropriate guidelines determine whether correction is indicated.
Test-Taking Pearl
Be suspicious of answers containing "always," "never," "absolute," or a single laboratory cutoff unless the question clearly establishes that standard. Board-style questions often reward integration rather than memorization of an isolated number.
Question 10: Device Performance Is Part of Patient Assessment
A patient is expected to require seven more days of peripherally compatible IV therapy. During the previous four hospital days, five short peripheral IVs have failed because of infiltration, leaking, or loss of patency. Each device was initially inserted successfully. The current PIV is functioning, but the patient reports increasing frustration and asks whether repeated IV starts are unavoidable.
What is the BEST response by the vascular access clinician?
A. Use the pattern of repeated device failure as part of reassessment and consider a more durable appropriate device.
B. Continue the current approach because successful insertion demonstrates that short peripheral access remains clinically suitable.
C. Insert a PICC because failure of multiple peripheral devices proves that peripheral therapy is no longer appropriate.
D. Replace peripheral catheters prophylactically each day so failure occurs under controlled circumstances rather than unexpectedly.
Correct Answer: A
Rationale
This question tests an easily missed component of vessel preservation: device performance over time.
The current Patient Assessment outline specifically references device-performance tracking as part of vessel-preservation strategy. Vascular Access Certification
Five devices failing in four days is meaningful patient-specific information. Even if each catheter was technically inserted correctly, the access strategy is not performing reliably.
Why A is correct: The clinician should step back and reassess rather than treating each failure as an isolated event. Therapy duration, infusate characteristics, available vessels, previous failures, complication risk, and alternative peripheral devices should be considered together.
Why B is misleading: Successful insertion and successful therapy completion are different outcomes. A catheter that repeatedly fails after placement is not providing reliable vascular access.
Why C is incorrect: Repeated PIV failure does not automatically mean a PICC is necessary. A midline, different PIV strategy, or another device may be more appropriate depending on the complete assessment.
Why D is incorrect: Routine prophylactic replacement does not solve the underlying failure pattern and creates additional vessel trauma.
Test-Taking Pearl
Don't judge vascular access success by "Did I get the line in?" The better question is: "Did the device safely and reliably support the prescribed therapy for the intended period?"
How to Approach Patient Assessment Questions on the VA-BC Exam
The most difficult patient-assessment questions rarely ask you to identify a vein or recite a single fact. Instead, they give you several pieces of clinically relevant information and expect you to determine which variable should drive the decision.
A useful approach is to mentally work through the case in this order:
What therapy is prescribed? Consider infusate characteristics, duration, frequency, and required lumens.
What does the medical history change? Look for CKD, thrombosis, vascular surgery, dialysis access, previous devices, cancer, coagulation abnormalities, or other vascular pathology.
What vascular resources should be preserved? The easiest vein today may not be the best vein to sacrifice.
What has already failed? Previous device performance is clinically meaningful.
Can the patient safely support the device? Consider cognition, development, communication, home environment, caregivers, supplies, and community resources.
Does the available imaging answer the actual question? A normal peripheral ultrasound does not necessarily exclude more proximal pathology.
Which answer addresses the whole patient rather than one isolated finding?
This type of analysis is consistent with the current VA-BC examination structure, which includes questions at recall, application, and analysis cognitive levels. Vascular Access Certification
Ready for More VA-BC Practice Questions?
Patient Assessment represents only one portion of the current VA-BC examination blueprint. Candidates should also be prepared for questions involving device assessment and selection, preparation, insertion, care and maintenance, complications, evidence-based practice, and legal and ethical considerations.
Want to see how the entire examination is weighted?
Review the Current VA-BC Exam Blueprint
Want another set of difficult clinical questions?
Try 10 VA-BC Clinical Scenario Practice Questions
Want to test yourself before purchasing a full exam?
Take the Free 10-Question VA-BC Practice Test
Ready for a full-length challenge?
Take the 150-Question VA-BC Comprehensive Practice Exam
